Acute and subacute oral toxicity characterization and safety assessment of COVID organics ® (Madagascar's Anti-COVID Herbal Tea) in animal models.

Autor: Aina OO; Department of Biochemistry and Nutrition, Centre for Research in Traditional, Complementary and Alternative Medicine, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria., Okoyenta OC; Department of Biochemistry and Nutrition, Centre for Research in Traditional, Complementary and Alternative Medicine, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria., Okolo CA; Department of Pathology, College of Medicine, University of Ibadan, University College Hospital, Ibadan, Oyo State, Nigeria., Kareem KO; Department of Biochemistry and Nutrition, Centre for Research in Traditional, Complementary and Alternative Medicine, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria., Ajibaye O; Department of Biochemistry and Nutrition, Centre for Research in Traditional, Complementary and Alternative Medicine, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria., Adeogun AO; Department of Biochemistry and Nutrition, Centre for Research in Traditional, Complementary and Alternative Medicine, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria., Salako BL; Department of Biochemistry and Nutrition, Centre for Research in Traditional, Complementary and Alternative Medicine, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria.
Jazyk: angličtina
Zdroj: Annals of African medicine [Ann Afr Med] 2023 Oct-Dec; Vol. 22 (4), pp. 481-488.
DOI: 10.4103/aam.aam_112_21
Abstrakt: Introduction: Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2. No drug has been generally approved as safe and effective for the treatment of COVID-19. Several therapeutic agents such as COVID Organics ® (CVO) have been explored as treatment options. CVO is an herbal tea composed of 62% of Artemisia annua and 38% of other plants. There is presently no existing scientific report and data on the safety and efficacy of CVO herbal drug. Thus, acute and subacute toxicity studies were undertaken to evaluate the safety and toxicity of CVO on short- and long-term usage in animal models.
Materials and Methods: Phytochemical and nutritional compositions of CVO were determined using standard methods. Acute oral toxicity was investigated using female Swiss albino mice (three per group). While subacute oral toxicity was done using female and male Swiss albino rats (five per group). The animals were administered 2000 mg/kg, 5000 mg/kg, therapeutic dose; 5500 mg/kg and supratherapeutic dose; 11,000 mg/kg of CVO herbal product. The control group received water ad libitum. The oral toxicity studies were done in accordance with Organization for Economic Corporation and Development guidelines. The experimental protocol was approved by the Institutional Animal Care and Use Committee, Nigerian Institute of Medical Research (Ethics No. IRB/17/043).
Results: CVO is rich in antioxidants: flavonoids (10.3%), tannins (29.1%), and phenolics (434.4 mg). It contains proteins (33.8%), carbohydrates (34.5%), fat (6.8%), and fiber (0.5%). In the acute toxicity study, no mortality was recorded in all the treated and untreated groups. The lethal dose of CVO is >5000 mg/kg body weight. The hematological, biochemical, lipid profile, and histologic parameters were all normal at therapeutic doses when compared to the control group.
Conclusion: The acute and subacute oral toxicity studies revealed that CVO is not toxic. The specific organ toxicity evaluations also indicated that CVO has no toxic effects on blood parameters and vital organs structure and function at therapeutic dose. Thus, CVO is safe for short- and long-term usage. We recommend that CVO should be subjected to efficacy studies to investigate whether it is effective for COVID-19 treatment as claimed by the manufacturer.
Competing Interests: None
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje